Rockwell Medical (RMTI) analyst forecast and price target
Analyst forecast
Consensus of 2 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $20.00 from $2.00 | Jul 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $2.00 from $2.50 | Mar 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $2.50 | Jan 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $2.50 from $3.00 | Nov 13, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 from $7.00 | Mar 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Dec 23, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $9.00 | Nov 25, 2024 |
| Rodman & Renshaw | Initiated Coverage | Buy | $5.00 | Nov 14, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Sep 11, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Sep 4, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Aug 12, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | May 16, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 from $11.00 | Mar 25, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Nov 15, 2023 |
| Maxim Group | Initiated Coverage | Buy | $5.00 | Oct 5, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Oct 4, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Sep 28, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Aug 15, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 from $9.00 | Jul 17, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 from $7.00 | May 30, 2023 |
Frequently asked questions
Is RMTI a buy, sell, or hold?
Analysts covering Rockwell Medical currently average a Buy rating: 2 buy, 0 hold and 0 sell, from 2 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on RMTI?
On Jul 9, 2026, HC Wainwright & Co. maintained Rockwell Medical at Buy with a price target of $20.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.